Microbiology exam 4

0.0(0)
Studied by 0 people
call kaiCall Kai
learnLearn
examPractice Test
spaced repetitionSpaced Repetition
heart puzzleMatch
flashcardsFlashcards
GameKnowt Play
Card Sorting

1/43

encourage image

There's no tags or description

Looks like no tags are added yet.

44 Terms

1
New cards

antimicrobial measures

 Sterilization

  • Destruction of ALL living cells, spores, and/or viruses

 Disinfection

  • Killing or removal of disease-producing organisms from inanimate surfaces

  • Does not necessarily result in sterilization

 Antisepsis

  • Removal of disease-producing organisms from the surface of living tissues, such as the skin

  • Does not necessarily result in sterilization

 Sanitization

  • Reducing microbial population to “safe” levels

  • Does not necessarily result in sterilization

 Cidal agents

  • Kill microbes

  • Lethal effects

 Bactericidal agents kill bacteria.

  • Fungicides, virucides, algicides, etc.

 Static agents

  • Inhibit or control microbial growth

  • Slow or stop metabolism or reproduction, but are not necessarily lethal

 Bacteriostatic agents inhibit bacterial growth.

  • Fungistatic, virustatic, algistatic, etc.


2
New cards

sterilizing and cidal agents kill exponentially

3
New cards

high temperature and pressure

4
New cards

pasteurization

5
New cards

cold

6
New cards

filtration

7
New cards

irradiation

8
New cards

chemical agents of disinfection

9
New cards

measuring the efficacy of disinfectants

10
New cards

commercial disinfectants

11
New cards

bacterial resistance to disinfectants

12
New cards

concepts of antimicrobial therapy (know table)

 Antibiotics - chemical compounds synthesized or naturally occurring ones produced by one microbes to selectively kill other microbes

  • A generic term for natural and synthesized antibiotics is chemotherapeutic agents

  • Antibiotics target bacteria only

 Selective toxicity: selectively kills or inhibits the pathogen, but not the host.

  • “Magic bullet” concept


<p> Antibiotics - chemical compounds synthesized or naturally occurring ones produced by one microbes to selectively kill other microbes</p><ul><li><p>A generic term for natural and synthesized antibiotics is chemotherapeutic agents</p></li><li><p>Antibiotics target bacteria only</p></li></ul><p> Selective toxicity: selectively kills or inhibits the pathogen, but not the host.</p><ul><li><p>“Magic bullet” concept</p></li></ul><p></p>
13
New cards

Bactericidal versus Bacteriostatic antibiotics

 In vitro tests for antibiotic effectiveness determine how little is needed to stop growth.

 Minimal inhibitory concentration (MIC)

  • Lowest concentration of the drug that will prevent growth of an organism

 Minimal bactericidal concentration (MBC)

  • Starts with MIC, requires plating of MIC “no growth” tubes to determine if any cells survived

  • what is the minimum concentration that will kill the bacteria i’m targeting

  • 1.0 is the minimum MIC to treat this bacteria


<p> In vitro tests for antibiotic effectiveness determine how little is needed to stop growth.</p><p> Minimal inhibitory concentration (MIC)</p><ul><li><p> Lowest concentration of the drug that will prevent growth of an organism</p></li></ul><p> Minimal bactericidal concentration (MBC)</p><ul><li><p> Starts with MIC, requires plating of MIC “no growth” tubes to determine if any cells survived</p></li><li><p>what is the minimum concentration that will kill the bacteria i’m targeting</p></li><li><p>1.0 is the minimum MIC to treat this bacteria </p></li></ul><p></p>
14
New cards

Kirby-Bauer assay

 Uses round filter-paper disks impregnated with different antibiotics, placed on a specialized agar (Mueller-Hinton) inoculated with a standard inoculum concentration

  • Zone of inhibition is measured around to determine the susceptibility of the organism to the antibiotic


15
New cards

determining whether an antibiotic is clinically useful - clinical considerations

 Clinical considerations

  • Drug concentration > MIC during treatment

  • Organ/ tissue interaction (Half life of drug over time, Toxicity, Allergic response)

 The chemotherapeutic index

  • Therapeutic dose: Minimum dose per kilogram of body weight that stops

pathogen growth

  • Toxic dose: Maximum dose tolerated by the patient

 Ratio of the toxic dose to the therapeutic dose is called chemotherapeutic index.

  • The higher the chemotherapeutic index, the safer the drug.


16
New cards

synergism and antagonism

 Combinations of antibiotics either work together or against each other

  • Synergistic: Drugs have greater effectiveness when used together (combined effect is greater than additive effect).

▪ Example: aminoglycoside + vancomycin

 Antagonistic: Drugs interfere with each other and decrease effectiveness.

▪ Example: penicillin + macrolides

17
New cards

targets of antimicrobial agents

  • know table


<ul><li><p>know table</p></li></ul><p></p>
18
New cards

drugs that target the cell wall

▪ Beta-lactam antibiotics

  • Enzymes that attach the disaccharide units to preexisting peptidoglycan and produce the peptide cross-links are collectively called penicillin-binding proteins.

  • Penicillin and related antibiotics bind to them.


19
New cards

microbial resistance to protect cell wall

 Bacteria may develop resistance by inheriting a gene encoding one of the beta-lactamase enzymes, which cleaves the beta-lactam ring structure of beta-lactam antibiotics.

 Random mutation in a gene for a penicillin-binding protein, in the cell wall, prevents

penicillin from binding and halting peptidoglycan synthesis.

 Bacteria have begun to develop extended-spectrum beta-lactamase (ESBL) enzymes,

which also confer resistance to beta-lactam antibiotics.

▪ Plasmid-borne; generally found in Enterobacteriaceae

 A mutation in a key penicillin-binding protein may also confer resistance to beta-

lactams.

▪ Method used by methicillin-resistant Staphylococcus aureus (MRSA)

20
New cards

drugs that target the bacterial membrane

▪ Poking holes in the bacterial cytoplasmic membrane eventually kills bacteria (gramicidin)

▪ Prevention of membrane synthesis (platensimycin)

21
New cards

drugs that affect DNA replication and integrity

 Selective toxicity for bacterial DNA

synthesis

 Metronidazole (Flagyl) Prodrug that is harmless until activated, which occurs after metabolism by microbial protein cofactors found specifically in anaerobic and microaerophilic bacteria.

 Quinolones

  • Inhibit DNA synthesis by blocking the action of DNA gyrase, preventing

the bacteria from regulating supercoiling

▪ Mammalian DNA gyrase is structurally distinct and thus not affected.

22
New cards

protein synthesis inhibitors

knowt flashcard image
23
New cards

drugs that affect intermediary metabolism

knowt flashcard image
24
New cards

challenges of antibiotic resistance

▪ The Centers for Disease Control and Prevention estimates that 35,000 people in the United States die every year from infections caused by antimicrobial-resistant (AMR) bacteria.

 Mechanisms that prevent intracellular accumulation

  • Destroy the antibiotic before it enters the cell

  • Pump antibiotics out of the cell

  • Decrease membrane permeability

 Mechanisms that prevent binding

  • Modify the target so that it no longer binds the antibiotic

  • Add modifying groups that inactivate the antibiotic

 Mechanism that dislodges the antibiotic

  • Ribosome protection (or rescue)


<p><span data-name="black_small_square" data-type="emoji">▪</span> The Centers for Disease Control and Prevention estimates that 35,000 people in the United States die every year from infections caused by antimicrobial-resistant (AMR) bacteria.</p><p> Mechanisms that prevent intracellular accumulation</p><ul><li><p> Destroy the antibiotic before it enters the cell</p></li><li><p> Pump antibiotics out of the cell</p></li><li><p> Decrease membrane permeability</p></li></ul><p> Mechanisms that prevent binding</p><ul><li><p>Modify the target so that it no longer binds the antibiotic</p></li><li><p>Add modifying groups that inactivate the antibiotic</p></li></ul><p> Mechanism that dislodges the antibiotic</p><ul><li><p>Ribosome protection (or rescue)</p></li></ul><p></p>
25
New cards

how does drug resistance develop

 Antibiotic treatment failure occurs when a patient treated with antibiotics appears to recover and the infection suddenly comes back.

 Transiently silent acquired AMR

▪ A newly identified problem: poorly expressed AMR genes don’t provide clinically relevant resistance until reactivated, which is often triggered by treatment.

 Persister cells

▪ Antibiotic-sensitive cells neither grow nor die in the presence of bactericidal antibiotics.

▪ Once antibiotics are discontinued, the cells regrow; they are dormant, not antibiotic-resistant.

26
New cards

antibiotic stewardship

a set of guidelines designed to slow the development of antibiotic-resistant microbes:

  • know when antibiotics should be administered

  • de-escalate antibiotic usage once the pathogen and subsequent resistance pattern is identified


27
New cards

fighting drug resistance

 Fake target compounds are used to inactivate resistance enzymes

  • Clavulanic acid: may be added to beta-lactam antibiotics to tie up beta-lactamase enzymes; allows beta-lactam to avoid destruction and kill the bacteria

▪ Multiple antibiotics with different modes of action may be administered simultaneously to reduce the likelihood of developing resistance.

▪ Antivirulence drugs are being developed to interfere with a pathogen’s ability to induce virulence factors, which makes it difficult to cause disease in the host.

28
New cards

Antibiotic stewardship

 A set of guidelines designed to slow the development of antibiotic-resistant

microbes:

  • Know when antibiotics should be administered

  • De-escalate antibiotic usage once pathogen and subsequent resistance

pattern is identified


29
New cards

virulence factors

 Virulence factors

• help establish a pathogen in the host

• disturb host functions

• enable transmission to new hosts

• Pathogenicity island: a genomic island that contains virulence factors,

generally identified

Examples of virulence factors:

– Pili

– Enzymes that harm the host or prevent detection

– Proteins that disrupt normal cellular function

– Capsule: completely cover and protect

– Enzymes that inactivate antibiotics

30
New cards

pathogenesis

the process by which a pathogen causes disease

 Steps:

 Entry into the host

 Attachment and colonization of tissue(s)

 Avoidance of host immunity

 Host damage

 Exit from host

 Repeat

31
New cards

pathogen attachment

 The human body has many ways to exclude pathogens. Pathogens must evade these mechanisms.

 Pathogen attachment

  • Adhesin: any microbial factor that promotes attachment

  • Types of adhesins

Pili: hairlike appendages

Fimbriae: short, bristle-like structures

Nonpilus adhesins

32
New cards

colonization and biofilm development

▪ Pathogens need nutrients for growth

▪ Biofilms = living cells + debris + dead cells + extracellular matrix

▪ Benefits:

 Adhesion

 Protection

 Prevents desiccation.

33
New cards

extracellular pathogens, immune avoidance

 Capsules

  • Opsonizing antibodies can bind to the capsule.

 Protein A can sequester antibodies by binding to Fc region of Ab -> prevent opsonization

 Changing of surface antigens (antigen shift)

 Quorum sensing can also help pathogens evade the immune system

34
New cards

intracellular pathogens

Facultative intracellular pathogens vs. Obligate intracellular pathogens

 Live inside host cell (ex. viruses)

 Benefits to pathogen:

  • Avoid innate and humoral immune response

  • Phagosome

 Thriving under stress

 Inhibiting phagosome-lysosome fusion

 Escaping from the phagosome

35
New cards

exotoxin modes of action

Two-subunit AB toxins

 A subunit = toxin (causes the damage)

 B subunit = binding (to host cell receptors)

36
New cards

endotoxin

only gram negative bacteria make endotoxin (LPS) - lipid A

  • part of the outer membrane (LPS)

Leads to a cytokine storm

 Fever

 Activation of clotting factors -> intravascular coagulation

 Activation of the alternative complement pathway

 Vasodilation, leading to hypotension

 Shock due to hypotension

 Death (severe)

37
New cards

protozoan pathogenesis

 Four major groups of protozoa, including the more commonly known pathogenic genera from each group:

 Amebas: Entamoeba (GI tract, amebic dysentery)

 Flagellates: Trypanosoma (blood infection, sleeping sickness), Leishmania (cutaneous or visceral leishmaniasis), Trichomonas (urogenital track; trichomoniasis), and Giardia (GI tract; giardiasis)

 Ciliates: Balantidium (GI tract, balantidiasis)

 Apicomplexans: Plasmodium (blood infection, malaria) and Toxoplasma (tissue cysts, toxoplasmosis)

  • immunosuppression via cytokine expression

  • antigenic shift (VSG in Trypanosomes)


38
New cards

fungal pathogenesis

Medically important fungi

May produce

  • Superficial mycoses of skin or hair

  • Systemic infections (target entire organism)

Two broad types of fungi

  • Molds that grow as long multicellular filaments, called hyphae or mycelia

  • Single-celled yeasts, which bud to replicate

May produce sexually or asexually

▪ Innate immune clearance

  • Pathogens – avoid clearance

  • Potential methods:

-Hide cell wall elements during the transition from mold to yeast forms

-Preventing acidification and lysosomal fusion

- Neutralizing reactive oxygen and nitrogen

- Metabolism - making own nutrients

39
New cards
40
New cards
41
New cards
42
New cards
43
New cards
44
New cards